Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Dr. Hoenle AG ( (DE:HNL) ) is now available.
Dr. Hoenle AG announced a managerial transaction involving the purchase of shares by Dr. Richter Vermögens- und Beteiligungsverwaltung GmbH, a member of the managing body. The transaction, which took place outside a trading venue, involved a total volume of 385,426.33 EUR at an aggregated price of 6.8035 EUR per share. This move could indicate confidence in the company’s future prospects and may impact stakeholder perceptions positively.
The most recent analyst rating on (DE:HNL) stock is a Hold with a EUR7.00 price target. To see the full list of analyst forecasts on Dr. Hoenle AG stock, see the DE:HNL Stock Forecast page.
More about Dr. Hoenle AG
Dr. Hoenle AG is a company involved in the industry of financial instruments, with a focus on shares. The company operates within the regulated market in Frankfurt and the free market in several German cities, including Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, and Tradegate.
Average Trading Volume: 5,539
Technical Sentiment Signal: Strong Sell
Current Market Cap: €41.22M
Find detailed analytics on HNL stock on TipRanks’ Stock Analysis page.